{
    "organizations": [],
    "uuid": "74f7c0e3cbbfaee0c578119ece6595f692a17f1f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-us-fda-approves-retacrit-as-biosim/brief-u-s-fda-approves-retacrit-as-biosimilar-to-epogen-procrit-for-treatment-of-anemia-idUSFWN1SM17B",
    "ord_in_thread": 0,
    "title": "BRIEF-U.S. FDA Approves Retacrit As Biosimilar To Epogen/Procrit For Treatment Of Anemia",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - The U.S. Food and Drug Administration:\n* SAYS APPROVED RETACRIT AS BIOSIMILAR TO EPOGEN/PROCRIT FOR TREATMENT OF ANEMIA\n* SAYS GRANTED APPROVAL OF RETACRIT TO HOSPIRA INC, A PFIZER COMPANY\n* SAYS AS WITH EPOGEN/PROCRIT, RETACRIT CONTAINS BOXED WARNING ABOUT INCREASED RISKS OF DEATH, HEART PROBLEMS, STROKE, TUMOR GROWTH OR RECURRENCE\n* SAYS APPROVAL OF RETACRIT FOR TREATMENT OF ANEMIA CAUSED BY CHRONIC KIDNEY DISEASE, CHEMOTHERAPY, OR USE OF ZIDOVUDINE IN PATIENTS WITH HIV INFECTION\n* SAYS RETACRIT HAS BEEN APPROVED AS A BIOSIMILAR, NOT AS AN INTERCHANGEABLE PRODUCT Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-15T23:54:00.000+03:00",
    "crawled": "2018-05-16T19:02:11.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "food",
        "drug",
        "administration",
        "say",
        "approved",
        "retacrit",
        "biosimilar",
        "treatment",
        "anemia",
        "say",
        "granted",
        "approval",
        "retacrit",
        "hospira",
        "inc",
        "pfizer",
        "company",
        "say",
        "retacrit",
        "contains",
        "boxed",
        "warning",
        "increased",
        "risk",
        "death",
        "heart",
        "problem",
        "stroke",
        "tumor",
        "growth",
        "recurrence",
        "say",
        "approval",
        "retacrit",
        "treatment",
        "anemia",
        "caused",
        "chronic",
        "kidney",
        "disease",
        "chemotherapy",
        "use",
        "zidovudine",
        "patient",
        "hiv",
        "infection",
        "say",
        "retacrit",
        "approved",
        "biosimilar",
        "interchangeable",
        "product",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}